Evidence map›Paper›PMID 36074917›Full record

ReviewAmerican journal of physiology. Renal physiology2022

Potential of soluble (pro)renin receptor in kidney disease: can it go beyond a biomarker?

Tianxin Yang

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in American journal of physiology. Renal physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Tianxin YangDepartment of Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah.ORCID 0000-0003-4209-2284
University of Utah · US

Funding

Interaction of PGE2 and intrarenal RAS in AngII-induced hypertensionR01DK104072 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI YANG, TIANXIN · 2015 to 2025
$3.7M
Adipose-derived sPRR controls circadian rhythm of blood pressure through inhibition of renal NCC activityR01HL160020 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI YANG, TIANXIN · 2022 to 2025
$2.4M
Role of (pro)renin receptor in aldosterone signaling in the kidneyR01HL139689 · NHLBI · UNIVERSITY OF UTAH · PI YANG, TIANXIN · 2018 to 2021
$2.3M
Interaction of (pro)renin receptor and PPARy in regulation of plasma volumeR01HL135851 · NHLBI · UNIVERSITY OF UTAH · PI YANG, TIANXIN · 2017 to 2021
$2.3M
BLRD VA I01 BX004871BLRD VA IK6 BX005223NHLBI NIH HHS R01 HL135851NHLBI NIH HHS R01 HL139689NHLBI NIH HHS R01 HL160020NIDDK NIH HHS R01 DK104072
6 · The paper itself

Abstract

(Pro)renin receptor (PRR), also termed ATPase H

Indexed as

Renal Insufficiency, ChronicVacuolar Proton-Translocating ATPasesAdenosine TriphosphatasesBiomarkersHumansKidneyProrenin ReceptorReceptor, Angiotensin, Type 1Receptors, Cell SurfaceReninRenin-Angiotensin SystemAdenosine TriphosphatasesATP6AP2 protein, humanBiomarkersProrenin ReceptorReceptor, Angiotensin, Type 1Receptors, Cell SurfaceReninVacuolar Proton-Translocating ATPasescollecting ductintercalated cellsintrarenal renin-angiotensin system(pro)renin receptorsite-1 proteasesoluble (pro)renin receptor

Identifiers

PMID36074917
PMCPMC9602801
OpenAlexW4295079333

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.